Clinical Trial Update: A Multi-centre, Double-blind, Randomized, Vehicle-controlled Study of Efficacy and Safety of Topical MOB015B in the Treatment of Mild to Moderate Distal Subungual Onychomycosis (DSO) [Phase 3]

View source ↗

Summary

Phase 3 trial completed evaluating topical MOB015B for distal subungual onychomycosis; study assessed efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Distal Subungual Onychomycosis

Drugs mentioned

• MOB015B (MOB015B)

Snippet

Sponsor: Moberg Pharma AB | Conditions: Distal Subungual Onychomycosis | Phase 3 | Status: COMPLETED